A Post-authorization Study to Describe the Safety and Efficacy of Emapalumab for the Treatment of pHLH in Treatment Experienced Chinese Patients
Clinical trial NCT05744063 · COMPLETED
Trial details
- NCT number
- NCT05744063
- Sponsor
- Swedish Orphan Biovitrum
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-03
- Primary completion
- 2025-02-21
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.